Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Oxide in Early Pregnancy After ICSI
NCT03398031Phase 3Unknown
- Sponsor
- Ain Shams University
- Start
- Jun 2017
- Primary completion
- Mar 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of magnesium oxide in spontaneous abortion, sponsored by Ain Shams University. Primary endpoint: First Trimesteric Abortion at 13 weeks. Status: unknown.
02
Drugs
magnesium oxide
03
Conditions
spontaneous abortion
Beyond the preview
Go deeper on NCT03398031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03398031.